Chronic intrahypothalamic rather than subcutaneous liraglutide treatment reduces body weight gain and stimulates the melanocortin receptor system.
Int J Obes (Lond)
; 41(8): 1263-1270, 2017 08.
Article
in En
| MEDLINE
| ID: mdl-28507313
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Weight Gain
/
Weight Loss
/
Receptors, Melanocortin
/
Liraglutide
/
Glucagon-Like Peptide-1 Receptor
/
Hypothalamus
Limits:
Animals
Language:
En
Journal:
Int J Obes (Lond)
Journal subject:
METABOLISMO
Year:
2017
Document type:
Article
Affiliation country:
Austria
Country of publication:
United kingdom